[ESPR] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
01-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 44.03%
YoY- 37.79%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 73,834 25,786 18,841 40,659 212,236 982 0 -
PBT -61,925 -49,935 -66,324 -43,668 124,611 -54,221 -45,730 5.17%
Tax 0 -51 13,948 11,153 4,721 0 0 -
NP -61,925 -49,935 -80,272 -43,668 124,611 -54,221 -45,730 5.17%
Tax Rate - - - - -3.79% - - -
Total Cost 135,759 75,721 99,113 84,327 87,625 55,203 45,730 19.86%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -83.87 -193.65 -426.05 -107.40 58.71 -5,521.49 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.33 -0.46 -1.27 -1.67 4.50 -2.01 -1.71 -23.96%
EPS Diluted -0.33 -0.46 -1.27 -1.67 4.32 -2.01 -1.71 -23.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.